BioTech Scout

Discover the most promising early-stage companies in life sciences, scouted by BioPharmaTrend. Follow company news and important business events.

back to Directory

neoX Biotech

neoX Biotech is a biotech company that combines artificial intelligence (AI) with biophysics for drug research and development. neoX focuses on the research and development of macromolecular drugs and multi-specific drugs, especially in the field of immuno-oncology. It has developed a sophisticated platform for early discovery of therapeutics by characterizing protein-protein interactions (PPI). neoX has established cooperation with biomedical companies globally to accelerate drug R&D pipelines. Founded in 2018 by two doctors graduated from MIT and Caltech, neoX has been funded by top venture capitals including Sequoia Capital, Morningside Venture Capital, Vision Plus Capital and ZhenFund.